Costa Rica vs Kazakhstan: New cases tested for RR-/MDR-TB
Costa Rica
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Costa Rica rank
1st
Kazakhstan rank
1st
New cases tested for RR-/MDR-TB over time
- Costa Rica
- Kazakhstan
How they compare
Costa Rica currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 2 times across 14 shared years of data; in 2008 it was Kazakhstan ahead.
Costa Rica ranks 1st and Kazakhstan ranks 1st of 192 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 28.0% | 28.0% | Kazakhstan |
| 2010s | 52.1% | 96.8% | 44.7% | Kazakhstan |
| 2020s | 70.8% | 100.0% | 29.2% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Costa Rica or Kazakhstan?
- Costa Rica, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Costa Rica and Kazakhstan?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Kazakhstan?
- 14 years are reported by both, from 2008 to 2024.
- How do Costa Rica and Kazakhstan rank globally for new cases tested for rr-/mdr-tb?
- Costa Rica ranks 1st and Kazakhstan ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.